July 27, 2014 | The Israeli company BrainStorm Cell Therapeutics is expected to receive a $5 million grant from the Brazilian Ministry of Health. The funds will go towards conducting trials on its product in conjunction with the University of Sao Paolo, according to “Globes.” The company has yet to respond to the reports, which are not yet official. BrainStorm Cell Therapeutics specializes in developing stem cell therapies for the treatment of neurodegenerative diseases such as ALS (Lou Gehrig’s disease), multiple sclerosis, and Parkinson’s disease.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
![](https://nocamels.com/wp-content/uploads/2018/02/INSIGHTEC-350x180.jpg)
Israeli Ultrasound Creator Collaborating On Neuroscience R&D In US
September 05, 2024
![The Weizmann Institute of Science. Photo via the Weizmann Institute of Science](https://nocamels.com/wp-content/uploads/2018/07/weizmann-350x252.jpg)
Weizmann In World’s Top 10 For Biomedical And Overall Research
September 05, 2024
![](https://nocamels.com/wp-content/uploads/2024/09/Depositphotos_75148477_L-350x228.jpg)
Israeli NGO Begins New Mental Health Training In Ukraine
September 04, 2024
![](https://nocamels.com/wp-content/uploads/2024/09/17123254699_79ff768811_ks-350x213.jpg)
Nonprofit Launches Loans For Stricken Northern Israel Businesses
September 04, 2024
Facebook comments